bluebird bio Inc (BLUE)
0.9273
-0.04
(-4.46%)
USD |
NASDAQ |
Apr 24, 16:00
0.92
-0.01
(-0.79%)
After-Hours: 20:00
bluebird bio Enterprise Value: 12.78M for April 23, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
April 23, 2024 | 12.78M |
April 22, 2024 | 9.506M |
April 19, 2024 | 22.30M |
April 18, 2024 | 9.39M |
April 17, 2024 | 11.38M |
April 16, 2024 | 16.58M |
April 15, 2024 | 24.23M |
April 12, 2024 | 37.72M |
April 11, 2024 | 49.29M |
April 10, 2024 | 55.07M |
April 09, 2024 | 68.56M |
April 08, 2024 | 49.29M |
April 05, 2024 | 62.78M |
April 04, 2024 | 62.78M |
April 03, 2024 | 53.14M |
April 02, 2024 | 58.92M |
April 01, 2024 | 64.71M |
March 28, 2024 | 72.42M |
March 27, 2024 | 88.80M |
March 26, 2024 | 57.00M |
March 25, 2024 | 87.84M |
March 22, 2024 | 89.76M |
March 21, 2024 | 107.11M |
March 20, 2024 | 95.55M |
March 19, 2024 | 95.55M |
Date | Value |
---|---|
March 18, 2024 | 103.26M |
March 15, 2024 | 99.40M |
March 14, 2024 | 82.05M |
March 13, 2024 | 93.62M |
March 12, 2024 | 84.94M |
March 11, 2024 | 93.62M |
March 08, 2024 | 114.82M |
March 07, 2024 | 105.18M |
March 06, 2024 | 105.18M |
March 05, 2024 | 93.62M |
March 04, 2024 | 120.60M |
March 01, 2024 | 127.35M |
February 29, 2024 | 93.62M |
February 28, 2024 | 149.51M |
February 27, 2024 | 163.01M |
February 26, 2024 | 107.11M |
February 23, 2024 | 66.63M |
February 22, 2024 | 53.14M |
February 21, 2024 | 35.80M |
February 20, 2024 | 37.72M |
February 16, 2024 | 22.30M |
February 15, 2024 | 33.87M |
February 14, 2024 | 23.27M |
February 13, 2024 | 15.10M |
February 12, 2024 | 35.80M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-292.21M
Minimum
Nov 08 2021
2.717B
Maximum
May 06 2019
479.18M
Average
243.41M
Median
Mar 01 2023
Enterprise Value Benchmarks
Novavax Inc | 185.91M |
Motus GI Holdings Inc | -2.321M |
Tivic Health Systems Inc | -1.731M |
Vertex Pharmaceuticals Inc | 93.30B |
AIM ImmunoTech Inc | 8.852M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -71.73M |
Revenue (Quarterly) | 12.39M |
Total Expenses (Quarterly) | 97.12M |
EPS Diluted (Quarterly) | -0.66 |
Gross Profit Margin (Quarterly) | 11.60% |
Profit Margin (Quarterly) | -578.8% |
Earnings Yield | -79.80% |
Normalized Earnings Yield | -79.80 |